Hosted on MSN4h
Citigroup Initiates Coverage of Candel Therapeutics (CADL) with Buy Recommendation
Fintel reports that on February 20, 2025, Citigroup initiated coverage of Candel Therapeutics (NasdaqGM:CADL) with a Buy ...
My Mother Made a Nearly Impossible Rule About Family Visits. I’m Going to Lose It.
The trouble is, she is getting increasingly upset with me each time I cancel. When I called this past weekend to let her know ...
Candel Therapeutics: Entering Its Pivotal Year
Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...
clickondetroit.com5h
What’s Going Around in Metro Detroit: Influenza, RSV, stomach viruses, Norovirus, COVID-19
We are still seeing RSV and COVID, though not as many cases as last week. There is an increase in adenovirus- especially in the college-age population, and GI illness is still around as well.” Dr.
Portfolio9h
Respiratory infections rise in Hungary after promising decline
After a promising decline on the 6th week of 2025, the number of people seeking medical help with respiratory infection, ...
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
TheHealthSite.com on MSN13h
Pope Francis Health: Head Of Vatican City Continues To Be In Hospital With Pneumonia Complications
The recent deterioration of his health has led to fears that the Pope may be in the final chapters of his life. He also ...